
Sign up to save your podcasts
Or


In the second part of this two-part series, Dr. Kaitlyn Palmer explains how these biomarkers change our approach to diagnosing multiple sclerosis.
Show reference:
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Montalban, Xavier, et al. The Lancet Neurology, Volume 24, Issue 10, 850 - 865
By American Academy of Neurology4.8
132132 ratings
In the second part of this two-part series, Dr. Kaitlyn Palmer explains how these biomarkers change our approach to diagnosing multiple sclerosis.
Show reference:
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Montalban, Xavier, et al. The Lancet Neurology, Volume 24, Issue 10, 850 - 865

321 Listeners

504 Listeners

299 Listeners

53 Listeners

298 Listeners

3,374 Listeners

16 Listeners

1,150 Listeners

24 Listeners

194 Listeners

94 Listeners

518 Listeners

367 Listeners

189 Listeners

80 Listeners